IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-62295-8.html
   My bibliography  Save this article

OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer

Author

Listed:
  • Peng Li

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Junjie Ye

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Qian Yang

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Ni Wang

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Chaoyi Li

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Xiaoxiao Zou

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Hanyan Luo

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Yi Pan

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Lingxi Jiang

    (Shanghai Jiao Tong University School of Medicine
    State Key Laboratory of Systems Medicine for Cancer)

  • Baiyong Shen

    (Shanghai Jiao Tong University School of Medicine
    State Key Laboratory of Systems Medicine for Cancer)

  • Zaiming Tang

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

  • Qing Zhong

    (Shanghai Jiao Tong University School of Medicine (SJTU-SM))

Abstract

BRCAness is a homologous recombination repair (HRR) deficiency phenotype mimicking BRCA1/2 loss, leading to PARP inhibitor sensitivity in BRCA-associated cancers including pancreatic cancer1–7. However, how to induce BRCAness in BRCA-proficient tumors remains unclear. We identify OFD1 as a positive regulator of BRCA1 in human pancreatic cancer cells and specimens, with its overexpression correlating with poor prognosis. OFD1 depletion impairs HRR and confers synthetic lethality with PARP inhibitors. Mechanistically, OFD1 interacts with E2F4 in the cytosol to prevent assembly of the transcriptional repressor DREAM complex at the BRCA1 promoter. Targeting OFD1 or disrupting its interaction with E2F4 promotes E2F4 nuclear translocation and DREAM complex formation, suppressing BRCA1 expression. OFD1 inhibition synergizes with olaparib in pancreatic cancer xenograft, spontaneous, and patient-derived xenograft models, and in other BRCA-associated cancer models. These findings reveal a mechanism of BRCA1 transcriptional regulation and highlight OFD1 as a therapeutic target to induce BRCAness in BRCA-proficient pancreatic cancer.

Suggested Citation

  • Peng Li & Junjie Ye & Qian Yang & Ni Wang & Chaoyi Li & Xiaoxiao Zou & Hanyan Luo & Yi Pan & Lingxi Jiang & Baiyong Shen & Zaiming Tang & Qing Zhong, 2025. "OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer," Nature Communications, Nature, vol. 16(1), pages 1-18, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62295-8
    DOI: 10.1038/s41467-025-62295-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-62295-8
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-62295-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62295-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.